創新藥物
創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1790.58 billion HKD，24h 漲跌幅 -0.86%，40 檔中，8 檔上漲 (20.00%)，29 檔下跌 (72.50%)。領漲個股為 樂普生物－Ｂ (02157)，24h 漲幅為 +4.27%。漲跌家數參差，板塊回落，但龍頭股表現相對優異。保持選擇性：圍繞臨床或政策催化事件操作；偏好現金充裕、處於後期臨床階段的研發管線，並在走弱時逢低加碼，因利率與給付/報銷訊號將影響估值。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 石藥集團01093 | HK$8.41$34.67 | +1.32%+$0.45 | HK$8.41 +1.32% | $34.17$35.53 | ||
 金斯瑞生物科技01548 | HK$16.93$69.79 | +0.65%+$0.45 | HK$16.93 +0.65% | $67.60$69.79 | ||
 信達生物－Ｂ01801 | HK$89.10$367.31 | -0.27%-$1.03 | HK$89.10 -0.27% | $363.80$371.43 | ||
 康諾亞－Ｂ02162 | HK$78.25$322.58 | -4.92%-$16.69 | HK$78.25 -4.92% | $318.87$342.37 | ||
 百濟神州06160 | HK$196.3$809.2 | -1.70%-$14.0 | HK$196.3 -1.70% | $808.4$826.1 | ||
 藥明康德02359 | HK$156.9$646.8 | -0.06%-$0.4 | HK$156.9 -0.06% | $642.2$653.8 | ||
 藥明生物02269 | HK$38.68$159.45 | +0.05%+$0.08 | HK$38.68 +0.05% | $158.05$160.36 | ||
 康方生物09926 | HK$95.70$394.52 | -2.94%-$11.95 | HK$95.70 -2.94% | $393.69$408.33 | ||
 晶泰控股02228 | HK$6.89$28.40 | -3.90%-$1.15 | HK$6.89 -3.90% | $28.32$29.97 | ||
 三生製藥01530 | HK$17.03$70.20 | -0.58%-$0.41 | HK$17.03 -0.58% | $69.83$70.70 | ||
 榮昌生物09995 | HK$84.25$347.31 | -1.63%-$5.77 | HK$84.25 -1.63% | $343.40$354.12 | ||
 藥明合聯02268 | HK$53.05$218.69 | -2.39%-$5.35 | HK$53.05 -2.39% | $218.69$225.91 | ||
 中國生物製藥01177 | HK$5.04$20.77 | -0.98%-$0.20 | HK$5.04 -0.98% | $20.73$21.18 | ||
 翰森製藥03692 | HK$32.28$133.07 | -0.06%-$0.08 | HK$32.28 -0.06% | $132.16$134.80 | ||
 樂普生物－Ｂ02157 | HK$4.63$19.08 | +4.27%+$0.78 | HK$4.63 +4.27% | $18.01$19.70 | ||
 恒瑞醫藥01276 | HK$57.40$236.63 | +0.61%+$1.44 | HK$57.40 +0.61% | $233.74$237.66 | ||
 巨子生物02367 | HK$29.00$119.55 | -0.13%-$0.16 | HK$29.00 -0.13% | $119.55$122.35 | ||
 科倫博泰生物－Ｂ06990 | HK$505.0$2,081.8 | -1.65%-$35.0 | HK$505.0 -1.65% | $2,075.6$2,118.9 | ||
 康哲藥業00867 | HK$11.91$49.09 | -0.91%-$0.45 | HK$11.91 -0.91% | $49.05$50.08 | ||
 ZAI LAB09688 | HK$14.76$60.84 | -0.73%-$0.45 | HK$14.76 -0.73% | $60.51$61.75 |